University of Patras
Επιδημιολογική μελέτη του καρκίνου του λάρυγγα στη Δυτική Ελλάδα και σύγκριση με άλλες ευρωπαϊκές χώρες
Abstract
dc:descriptionObjective: This doctoral dissertation aims to conduct a comprehensive, multi-level epidemiological study of laryngeal cancer, focusing on the documentation of the demographic and clinical characteristics of patients in Western Greece, the analysis of overall and disease-specific survival (OS and DSS) and their prognostic factors, the comparison of key epidemiological indicators at the European level, and the investigation of the impact of economic indicators on the Mortality-to-Incidence Ratio (MIR). Materials and Methods: A retrospective study was conducted on a series of patients diagnosed and treated for laryngeal cancer at the Otorhinolaryngology (ENT) Department of the University General Hospital of Patras (UGHP) during the period 1997–2017. The prognostic factors examined included gender, age, occupation, tobacco and alcohol use, histological tumor type, disease staging, anatomical tumor location, treatment modality, and patient outcome. Survival curves were estimated using the Kaplan-Meier method, and multivariate analysis was performed using Cox regression. Stratified curves were compared using the log-rank test. The epidemiological comparison between European countries was based on secondary data from the Global Burden of Disease (GBD) database of the Institute for Health Metrics and Evaluation (IHME) for the period 1997–2021. The data included age-standardized rates (ASRs) of incidence and mortality, the mortality-to-incidence ratio (MIR), as well as disability-adjusted life years (DALYs). Additionally, multiple linear regression was used to explore the relationship between economic indicators (GDP per capita and health expenditure/funding) and the MIR. The classification of countries and grouping into European regions followed the categories established by IHME and the United Nations, respectively. Statistical analysis was conducted using the Statistical Package for the Social Sciences (SPSS) and Microsoft Excel 365. All statistical tests were considered significant at p ≤ 0.05. Results: A total of 211 cases of laryngeal cancer were recorded between 1997 and 2017, with a mean age at diagnosis of 62.67 years and a marked male predominance (95.3%). Most patients were smokers (97.6%), with a mean value of 88.15 pack-years. TNM staging revealed that 88.6% of patients were diagnosed at advanced stages (III–IV), with 46.9% at stage IV and 41.7% at stage III. The glottic region was the most common tumor location (61.1%), followed by the supraglottic (36%) and subglottic (2.8%) regions. The most frequent occupational groups were farmers (26.1%), construction workers (19.4%), and self-employed professionals (13.3%). Regarding tumor size, 46.9% of patients had T4 tumors, 41.7% T3, and only 11.4% T2, indicating frequent late-stage diagnosis at the local level. Tumor differentiation showed that most patients (64.4%) had moderately differentiated tumors (Grade 2), while 18.8% had poorly differentiated (Grade 3) and 16.8% well-differentiated (Grade 1) tumors. All patients (100%) underwent some form of surgery, primarily total laryngectomy (99.1%), while 77.3% underwent neck dissection. Additionally, 36% of patients received radiotherapy alone, and 27% received combined chemoradiotherapy. The mean overall survival (OS) was 91.87 months (95% CI: 78.27–105.48), with survival rates at 1, 3, 5, and 10 years being 87.6%, 57.6%, 47%, and 28.1%, respectively. Disease-specific survival (DSS) rates for the same intervals were 89.3%, 60.2%, 50.8%, and 35.2%, respectively. Mean survival differed significantly by disease stage: 88.05 months for stage II, 82.02 months for stage III, and 53.13 months for stage IV (p < 0.001). Tumor size also affected prognosis, with mean survival of 82.91 months for T2, 78.60 months for T3, and 52.38 months for T4 tumors (p < 0.001). Lymph node involvement significantly impacted survival as well (p < 0.001), with mean survival of 75.08 months for N0 and only 26.55 months for N1. Among occupational groups, civil servants showed the highest mean survival (109.40 months), with 5- and 10-year survival rates of 90% and 60%, respectively (p = 0.033). Multivariate Cox regression identified tumor size (Exp(B) = 2.196, p = 0.016), lymph node involvement (Exp(B) = 1.647, p = 0.002), and alcohol consumption (Exp(B) = 1.382, p = 0.021) as independent prognostic factors significantly affecting overall survival.At the European level, secondary data analysis (1997–2021) revealed a clear downward trend in all major epidemiological indicators of laryngeal cancer—incidence, mortality, MIR, and DALYs. The mean DALY rate decreased by approximately 42%, from 76.37 to 44.44 per 100,000 population (R² = 0.99, p < 0.001), while MIR dropped from 0.563 in 1997 to 0.459 in 2021, showing a significant downward trend (R² = 96.26%, p < 0.001). Northern Europe showed improvement in MIR from 0.448 to 0.355, while Western Europe consistently maintained the lowest MIR values throughout the period (from 0.388 to 0.326). Specifically, Finland (MIR = 0.252), France (0.263), Sweden (0.276), Ireland (0.274), and Norway (0.278) had the most favorable survival indicators. In contrast, although Eastern Europe showed a decline (from 0.690 to 0.565), it continued to exhibit the highest MIR values. Southern Europe also showed high initial MIR values (0.575 in 1997), which decreased to 0.465 by 2021. However, notable intraregional disparities were observed, with countries such as Montenegro and Serbia exhibiting the highest incidence in the region (up to 9.9 cases per 100,000), while Greece showed intermediate levels, with a rate of 4.48 in 2021—slightly above the European average. In Greece, although a declining trend was observed, MIR and DALY values remained higher than in Northern and Western Europe, with MIR reaching 0.368 and DALYs 42,53 per 100,000 in 2021. Furthermore, a strong and statistically significant negative correlation was found between economic indicators and MIR (p < 0.001). Conclusions: This doctoral dissertation confirms that survival in laryngeal cancer patients depends largely on early diagnosis, while factors such as disease stage, lymph node involvement, tumor size, alcohol consumption, and occupation emerge as critical prognostic indicators. The widespread presence of smoking and alcohol consumption among patients highlights their role as key behavioral risk factors. The comparison between European countries and regions revealed substantial geographic disparities in incidence, mortality, and cancer management, reflecting both public health progress and systemic challenges. Northern Europe shows lower incidence rates, likely due to effective preventive measures, while Western Europe stands out for its superior disease management, registering the lowest MIR. Greece, although following the general European downward trend, continues to report higher values compared to Northern and Western Europe. Additionally, the findings suggest that health investments and levels of economic development play a critical role in improving prognosis and reducing mortality from laryngeal cancer. The results underscore the need for targeted policy interventions focused on prevention, early diagnosis, reduction of inequalities, and universal access to high-quality oncological care.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Avdulla, Christos
- Αβντουλλά, Χρήστος
Subjects
dc:subject × 32- Καρκίνος του Λάρυγγα
- Επιδημιολογία
- Προγνωστικοί παράγοντες
- Συνολική επιβίωση (OS)
- Νόσο-ειδική επιβίωση (DSS)
- Επίπτωση
- Θνησιμότητα
- Δείκτης αναλογίας θνησιμότητας προς επίπτωση (MIR)
- Έτη ζωής προσαρμοσμένα ως προς την αναπηρία (DALYs)
- Ελλάδα
- Ευρώπη
- Πολιτικές υγείας
- Laryngeal cancer
- Epidemiology
- Prognostic factors
- Overall survival (OS)
- Disease-specific survival (DSS)
- Incidence
- Mortality
- Mortality-to-incidence ratio (MIR)
- Disability-adjusted life years (DALYs)
- Greece
- Europe
- Health policy
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Ογκολογία
- Health Sciences
- Medical and Health Sciences
- Clinical Medicine
- Oncology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61107